Utility and limitations of noninvasive fibrosis markers for predicting prognosis in biopsy-proven Japanese non-alcoholic fatty liver disease patients

Journal of Gastroenterology and Hepatology
Takanori ItoYoshiki Hirooka

Abstract

The fibrosis stage of non-alcoholic fatty liver disease (NAFLD) is closely associated with long-term prognosis, including liver-related mortality. However, it is not yet clear whether noninvasive fibrosis markers can predict the incidence of non-liver-related complications in Japanese NAFLD. In this study, we clarified the prognosis of NAFLD patients, including non-liver-related diseases, based on hepatic pathology and noninvasive fibrosis markers. A total of 246 Japanese patients with NAFLD diagnosed by liver biopsy were enrolled. We investigated their prognosis based on hepatic pathology and noninvasive fibrosis markers. When these patients were categorized based on the severity of liver fibrosis as F0-2 (n = 196) and F3-4 (n = 50), the patients with F3-4 had significantly poorer prognosis in overall survival rates and all complications (P < 0.05). The fibrosis-4 (FIB-4) index was useful to predict overall survival and the incidence of hepatocellular carcinoma and liver cirrhosis (LC)-related complications but not extrahepatic malignancies. Multiple logistic regression analyses revealed the following risk factors: total bilirubin ≥ 1.2 (hazard ratio [HR] 6.362, 95% confidence interval [CI] 1.393-29.052) and severe liver fibro...Continue Reading

References

Sep 14, 1999·The American Journal of Gastroenterology·E M BruntB R Bacon
May 27, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Richard K SterlingUNKNOWN APRICOT Clinical Investigators
Mar 30, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Paul AnguloChristopher P Day
Jun 16, 2009·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Amy G ShahUNKNOWN Nash Clinical Research Network
Nov 3, 2010·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Herbert Tilg, Alexander R Moschen
Mar 2, 2011·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiZachary Goodman
Jan 10, 2012·BMC Gastroenterology·Yoshio SumidaUNKNOWN Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD)
Nov 24, 2012·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Donghee KimTerry M Therneau
Sep 18, 2013·Nature Reviews. Gastroenterology & Hepatology·Rohit Loomba, Arun J Sanyal
Dec 21, 2013·Diabetes Care·UNKNOWN American Diabetes Association
Aug 16, 2014·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Mattias EkstedtRolf Hultcrantz
Dec 4, 2014·The Lancet Oncology·Melina ArnoldIsabelle Soerjomataram
Aug 15, 2015·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zobair M YounossiSharon Hunt
Jan 27, 2016·Digestive Diseases and Sciences·Alessandro MantovaniGiovanni Targher
Sep 18, 2016·Journal of Gastroenterology·Wai-Kay Seto, Man-Fung Yuen
Dec 3, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ana Elisa LohmannRyan J O Dowling
Jan 29, 2017·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Julie K HeimbachJorge A Marrero

❮ Previous
Next ❯

Citations

Feb 25, 2020·Liver International : Official Journal of the International Association for the Study of the Liver·Ki-Chul SungChristopher D Byrne
Dec 30, 2020·The Journal of International Medical Research·Umesh JayarajahSuranjith L Seneviratne
Oct 27, 2020·JGH Open : an Open Access Journal of Gastroenterology and Hepatology·Masahiro OgawaShuji Terai
Dec 23, 2020·Nature Reviews. Gastroenterology & Hepatology·Daniel Q HuangRohit Loomba
Sep 18, 2021·Hepatology Research : the Official Journal of the Japan Society of Hepatology·Katsutoshi TokushigeKazuhiko Koike
Sep 18, 2021·Journal of Gastroenterology·Katsutoshi TokushigeKazuhiko Koike

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.